Guidelines for allergic rhinitis in primary health care;Guía de actuación ante una rinitis alérgica en atención primaria

ORL-DIPS

Volumn 28, Issue 4, 2001, Pages 190-199

  Negro, J Ma ^a   Periago, J ^a   Navarro, C ^a   Lopez J D ^a   Sanchez ^a   Pagan J A ^a   Garcia Selles F J ^a  

^a Residencial La Paloma   (Spain)

Author keywords

Allergic rhinitis; Antihistamines; Costs; Cromones; Descongestants; Immunotherapy; Ipratropium bromide; Nasal steroids

Indexed keywords

ANTIHISTAMINIC AGENT; DECONGESTIVE AGENT; IPRATROPIUM BROMIDE; STEROID;

ALLERGIC RHINITIS; ARTICLE; DEVELOPED COUNTRY; EUROPE; HUMAN; IMMUNOTHERAPY; NOSE OBSTRUCTION; PRACTICE GUIDELINE; PREVALENCE; PRIMARY HEALTH CARE; RHINORRHEA; SYMPTOMATOLOGY;

EID: 0035663684     PISSN: 02107309     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Consensus statement on the treatment of allergic rhinithis
2. Prevalence of allergic diseases in schoolchildren in relation to family history, upper respiratory tract infections, and residential characteristics
3. Learning impairment and allergic rhinitis
4. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders
5. Chemokines in seasonal allergic rhinitis
6. Mite asthma and residency. A case-control study of the impact of exposure to house-dust mites in dwellings
7. International consensus report on the diagnosis and management of rhinitis
8. Pulmonary function and bronchial hyperreactivity in asthmatic children with house dust mite allergy during prolonged stay in Italian Alps
9. The nasal allergic reaction: Observations on the role of histamine
10. 1 receptor antagonist drugs
11. Non-sedating antihistamines and cardiac arrythmia
12. Levocavastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjuntivitis
13. Azelastine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutical therapeutical potential
14. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis
15. Allergic rhinitis and inflammation: The effect of nasal corticosteroid therapy
16. Intranasal corticosteroids versus oral H-receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials
17. Inhaled and nasal corticosteroids: Safety aspects
18. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: A safety and biopsy study
19. Inhibition of neutrophil and eosinophil chemotaxis by nedocromil and sodium cromoglycate
20. Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children
21. Double-blind group comparative study of 2% nedocromil sodium eye drops with placebo eye drops in the treatment of seasonal allergic conjunctivitis
22. Product characteristics and pharmacokinetics of intranasal ipratropium bromide
23. Vasoconstrictors
24. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper
25. The treatment of allergic rhinitis with immunotherapy: A review of 1,000 cases
26. Long-term risk factors for developing asthma and allergic rhinitis: A 23 year follow-up study of college students
27. Preventive aspects of immunotherapy: Prevention for children at risk of developing asthma
28. Specific immunotherapy in rhinitis and asthma
29. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitization in children
30. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study
31. CSM update. Desensitizing vaccines
32. The position of immunotherapy in European Academy of Allergology and Clinical Immunology